175 related articles for article (PubMed ID: 17555418)
1. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis.
Manguso F; Balzano A
Aliment Pharmacol Ther; 2007 Jul; 26(1):21-9. PubMed ID: 17555418
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Zhao X; Li N; Ren Y; Ma T; Wang C; Wang J; You S
PLoS One; 2016; 11(8):e0160500. PubMed ID: 27501314
[TBL] [Abstract][Full Text] [Related]
3. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
[TBL] [Abstract][Full Text] [Related]
4. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F
Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061
[TBL] [Abstract][Full Text] [Related]
5. Oral beclomethasone dipropionate in pediatric active ulcerative colitis: a comparison trial with mesalazine.
Romano C; Famiani A; Comito D; Rossi P; Raffa V; Fries W
J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):385-9. PubMed ID: 20179636
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Manguso F; Bennato R; Lombardi G; Riccio E; Costantino G; Fries W
PLoS One; 2016; 11(11):e0166455. PubMed ID: 27846307
[TBL] [Abstract][Full Text] [Related]
8. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.
Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M
Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960
[TBL] [Abstract][Full Text] [Related]
9. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.
Gionchetti P; D'Arienzo A; Rizzello F; Manguso F; Maieron R; Lecis PE; Valpiani D; Iaquinto G; Annese V; Balzano A; Varoli G; Campieri M;
J Clin Gastroenterol; 2005 Apr; 39(4):291-7. PubMed ID: 15758622
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Cohen RD; Woseth DM; Thisted RA; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
[TBL] [Abstract][Full Text] [Related]
12. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].
Rufle W; Frühmorgen P; Huber W; Kimmig JM
Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860
[TBL] [Abstract][Full Text] [Related]
13. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis.
Mulder CJ; Fockens P; Meijer JW; van der Heide H; Wiltink EH; Tytgat GN
Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):549-53. PubMed ID: 8823568
[TBL] [Abstract][Full Text] [Related]
14. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2010 Jan; (1):CD004115. PubMed ID: 20091560
[TBL] [Abstract][Full Text] [Related]
15. [The topical therapy of ulcerative colitis. A multicenter study with beclomethasone dipropionate foam].
Arcidiacono R; Zanasi G; Pirone Z; Borzio M; Borzio F; Milano G; Cestari L; Ravelli P; Terraroli C; de Franchis R; Vecchi M; Galeone M; Toti GL; Cacioli D; Luminari L; Giannelli C; Gioiemi A; Russello D; Di Blasi M; Di Stefano A; Russo A; Aprile G; Biraghi M
Minerva Chir; 1999 Sep; 54(9):635-44. PubMed ID: 10549210
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis.
Zhao X; Zhou C; Ma J; Zhu Y; Sun M; Wang P; Zhang Y; Ma H; Zhang H
Sci Rep; 2017 Apr; 7():46693. PubMed ID: 28440311
[TBL] [Abstract][Full Text] [Related]
17. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial on absorption and N-acetylation of oral and rectal mesalazine.
Dilger K; Trenk D; Rössle M; Cap M; Zähringer A; Wacheck V; Remmler C; Cascorbi I; Kreisel W; Novacek G
Eur J Clin Invest; 2007 Jul; 37(7):558-65. PubMed ID: 17576207
[TBL] [Abstract][Full Text] [Related]
19. Ulcerative proctitis: a review of pharmacotherapy and management.
Lakatos PL; Lakatos L
Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952
[TBL] [Abstract][Full Text] [Related]
20. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
Lichtenstein GR; Kamm MA; Sandborn WJ; Lyne A; Joseph RE
Aliment Pharmacol Ther; 2008 Jun; 27(11):1094-102. PubMed ID: 18363894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
